We at NeuroTrials Research are looking forward to attending the DIA Annual Meeting in D.C. and interacting with a variety of industry professionals
Atlanta, GA (Vocus) May 27, 2010
NeuroTrials Research, Inc. will exhibit at the upcoming 46th Drug Information Association (DIA) Annual Meeting along with more than 400 other companies from June 13-17th, 2010 in Washington, DC. NeuroTrials Research, Inc. will exhibit information regarding its services in investigational drug research and diagnostic testing. NeuroTrials specializes in the therapeutic areas of Neurology and Sleep Disorders, but also performs Psychiatry and Pulmonary clinical research studies. Clinical trials that are performed at NeuroTrials range from Phase I to Phase IV.
“We at NeuroTrials Research are looking forward to attending the DIA Annual Meeting in D.C. and interacting with a variety of industry professionals,” said Kathy Jones Beals, the company’s COO and VP of Business Development. “After a successful year of conducting many clinical research studies in neurology, sleep medicine, and other areas, we felt that 2010 was a great time to begin exhibiting at the DIA Annual Meeting,” said Dr. Russell Rosenberg, the CEO and Director of Research at NeuroTrials.
NeuroTrials Research Inc. will be located at booth number 2345 in the exhibit hall during the 5-day event.
The conference, which will be held at the Walter E. Washington Convention Center, will feature exhibits, speakers and networking opportunities. The 2010 Networking Reception is set to take place at the Newseum and will showcase the Berlin Wall Gallery and the Pulitzer Prize Photographs Gallery.
NeuroTrials Research, Inc. is located in the Perimeter area of Atlanta, GA, a convenient location for people living in the metro Atlanta area. “NeuroTrials Research has the largest and most advanced sleep research laboratory in the Southeast, and we feel we will bring unique capabilities and expertise to the DIA Exhibit Hall,” said Jones Beals.
The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. There is no other industry meeting of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content-area tracks, 330 sessions, and 20 tutorials, presentations are geared to attendees at all disciplines, works settings, and experience levels.
ABOUT NEUROTRIALS RESEARCH:
NeuroTrials Research, Inc. is an independent research organization devoted exclusively to investigational drug research and diagnostic testing, specializing in the Central Nervous System (CNS) area. Clinical trials that are performed at NeuroTrials are Phase I – IV. Founded in 1997, NeuroTrials Research has grown to include a network of investigators with special expertise in: Neurology, Psychology, Psychiatry, Sleep Medicine, Pulmonary Medicine and Internal Medicine. Today, NeuroTrials Research has the largest and most advanced sleep research laboratory in the Southeast with the ability to run studies night or day, seven days a week. NeuroTrials’ professional team of experienced clinical research staff is dedicated to the safety and well-being of its subjects and the accuracy of research for its clients. NeuroTrials Research was founded by Dr. Russell Rosenberg who now serves as CEO, the Director of Research, and an investigator. Dr. Rosenberg also serves as CEO for NeuroTrials’ two partner companies: The Atlanta School of Sleep Medicine, and The Atlanta Sleep Medicine Clinic. For more information about NeuroTrials Research and to see its currently enrolling studies, please visit http://www.neurotrials.com/. Media Contact: Laura Baareman, (404)851-9934.
ABOUT THE DRUG INFORMATION ASSOCIATION (DIA):
DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery and development of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.